Sharpe, E. F., Kingston, A. E., Lodge, D., Monn, J. A., & Headley, P. M. (2002). Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo.

Sharpe, E F., A E. Kingston, D. Lodge, J A. Monn, and P M. Headley. Systemic Pre-treatment With a Group II MGlu Agonist, LY379268, Reduces Hyperalgesia in Vivo. 2002.

Sharpe, E F., et al. Systemic Pre-treatment With a Group II MGlu Agonist, LY379268, Reduces Hyperalgesia in Vivo. 2002.